Transl Clin Pharmacol.
2018 Sep;26(3):143-143. 10.12793/tcp.2018.26.3.143.
Erratum: Population Pharmacokinetic Analysis of Metformin Administered as Fixed-Dose Combination in Korean Healthy Adults
- KMID: 2420299
- DOI: http://doi.org/10.12793/tcp.2018.26.3.143
Abstract
- In the published version of this article, the contents of Table 1 ("˜Demographic characteristics of subjects') are incorrect.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults
- Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects
- Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
- Use of SGLT2 inhibitor/metformin fixed dose combination in Korea
- Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions
